Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2016, Article ID 9529630, 10 pages
http://dx.doi.org/10.1155/2016/9529630
Research Article

Icariin Prevents Cartilage and Bone Degradation in Experimental Models of Arthritis

Department of Orthopaedics and Traumatology, Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai University of TCM, Shanghai 200071, China

Received 25 January 2016; Revised 27 March 2016; Accepted 3 April 2016

Academic Editor: Giuseppe Valacchi

Copyright © 2016 Chen Chao Wei et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. N. Lesuis, R. Befrits, F. Nyberg, and R. F. van Vollenhoven, “Gender and the treatment of immune-mediated chronic inflammatory diseases: rheumatoid arthritis, inflammatory bowel disease and psoriasis: an observational study,” BMC Medicine, vol. 10, article 82, 2012. View at Publisher · View at Google Scholar · View at Scopus
  2. D. G. Adlowitz, J. Barnard, J. N. Biear et al., “Expansion of activated peripheral blood memory B cells in rheumatoid arthritis, impact of B cell depletion therapy, and biomarkers of response,” PLoS ONE, vol. 10, no. 6, Article ID e0128269, 2015. View at Publisher · View at Google Scholar · View at Scopus
  3. N. Meednu, H. Zhang, T. Owen et al., “Production of RANKL by memory B cells: a link between B cells and bone erosion in rheumatoid arthritis,” Arthritis & Rheumatology, vol. 68, no. 4, pp. 805–816, 2016. View at Publisher · View at Google Scholar
  4. Á. Horváth, A. Pusztai, K. Gulyás et al., “A4.3 Effects of anti-TNF therapy on markers of bone homeostasis in rheumatoid arthritis and ankylosing spondylitis,” Annals of the Rheumatic Diseases, vol. 74, no. 2, article A37, 2015. View at Publisher · View at Google Scholar
  5. S. Fadda, A. Hamdy, E. Abulkhair, H. Mahmoud Elsify, and A. Mostafa, “Serum levels of osteoprotegerin and RANKL in patients with rheumatoid arthritis and their relation to bone mineral density and disease activity,” The Egyptian Rheumatologist, vol. 37, no. 1, pp. 1–6, 2015. View at Publisher · View at Google Scholar · View at Scopus
  6. D. Lin, L. Li, Y. Sun et al., “Interleukin17 regulates the expressions of RANKL and OPG in human periodontal ligament cells via TRAF6/TBK1JNK/NF‐κB pathways,” Immunology, vol. 144, no. 3, pp. 472–485, 2015. View at Publisher · View at Google Scholar
  7. H. Raghu, C. Cruz, C. L. Rewerts et al., “Transglutaminase factor XIII promotes arthritis through mechanisms linked to inflammation and bone erosion,” Blood, vol. 125, no. 3, pp. 427–437, 2015. View at Publisher · View at Google Scholar
  8. H. Shao, J. Shen, M. Wang et al., “Icariin protects against titanium particle-induced osteolysis and inflammatory response in a mouse calvarial model,” Biomaterials, vol. 60, pp. 92–99, 2015. View at Publisher · View at Google Scholar · View at Scopus
  9. C. Li, Q. Li, Q. Mei, and T. Lu, “Pharmacological effects and pharmacokinetic properties of icariin, the major bioactive component in Herba Epimedii,” Life Sciences, vol. 126, pp. 57–68, 2015. View at Publisher · View at Google Scholar · View at Scopus
  10. L. Chi, W. Gao, X. Shu, and X. Lu, “A natural flavonoid glucoside, icariin, regulates th17 and alleviates rheumatoid arthritis in a murine model,” Mediators of Inflammation, vol. 2014, Article ID 392062, 10 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  11. R. Shen, W. Deng, C. Li, and G. Zeng, “A natural flavonoid glucoside icariin inhibits Th1 and Th17 cell differentiation and ameliorates experimental autoimmune encephalomyelitis,” International Immunopharmacology, vol. 24, no. 2, pp. 224–231, 2015. View at Publisher · View at Google Scholar · View at Scopus
  12. P. Sun, Y. Liu, X. Deng et al., “An inhibitor of cathepsin K, icariin suppresses cartilage and bone degradation in mice of collagen-induced arthritis,” Phytomedicine, vol. 20, no. 11, pp. 975–979, 2013. View at Publisher · View at Google Scholar · View at Scopus
  13. F. Wang, Z. Liu, S. Lin, H. Lu, and J. Xu, “Icariin enhances the healing of rapid palatal expansion induced root resorption in rats,” Phytomedicine, vol. 19, no. 11, pp. 1035–1041, 2012. View at Publisher · View at Google Scholar · View at Scopus
  14. T. P. LaBranche, M. I. Jesson, Z. A. Radi et al., “JAK inhibition with tofacitinib suppresses arthritic joint structural damage through decreased RANKL production,” Arthritis & Rheumatism, vol. 64, no. 11, pp. 3531–3542, 2012. View at Publisher · View at Google Scholar · View at Scopus
  15. D. L. Asquith, A. M. Miller, I. B. McInnes, and F. Y. Liew, “Animal models of rheumatoid arthritis,” European Journal of Immunology, vol. 39, no. 8, pp. 2040–2044, 2009. View at Publisher · View at Google Scholar
  16. R. Largo, O. Sánchez-Pernaute, M. E. Marcos et al., “Chronic arthritis aggravates vascular lesions in rabbits with atherosclerosis: a novel model of atherosclerosis associated with chronic inflammation,” Arthritis & Rheumatism, vol. 58, no. 9, pp. 2723–2734, 2008. View at Publisher · View at Google Scholar · View at Scopus
  17. L. Santos, P. Hall, C. Metz, R. Bucala, and E. F. Morand, “Role of macrophage migration inhibitory factor (MIF) in murine antigen-induced arthritis: interaction with glucocorticoids,” Clinical and Experimental Immunology, vol. 123, no. 2, pp. 309–314, 2001. View at Publisher · View at Google Scholar · View at Scopus
  18. R. U. Kleeman, D. Krocker, A. Cedrano, J. Tuischer, and G. N. Duda, “Altered cartilage mechanics and histology in knee osteoarthritis: relation to clinical assessment (ICRS Grade),” Osteoarthritis and Cartilage, vol. 13, no. 11, pp. 958–963, 2005. View at Publisher · View at Google Scholar · View at Scopus
  19. A. Fioravanti, E. Moretti, G. Scapigliati, R. Cervone, M. Galeazzi, and G. Collodel, “Morphological, immunocytochemical and biochemical studies in human osteoarthritic chondrocytes exposed to IL-1β and cyclical hydrostatic pressure,” Clinical and Experimental Rheumatology, vol. 25, no. 5, pp. 690–695, 2007. View at Google Scholar · View at Scopus
  20. M. M. Abouheif, T. Nakasa, H. Shibuya, T. Niimoto, W. Kongcharoensombat, and M. Ochi, “Silencing microRNA-34a inhibits chondrocyte apoptosis in a rat osteoarthritis model in vitro,” Rheumatology, vol. 49, no. 11, pp. 2054–2060, 2010. View at Publisher · View at Google Scholar · View at Scopus
  21. T. D. Schmittgen and K. J. Livak, “Analyzing real-time PCR data by the comparative CT method,” Nature Protocols, vol. 3, no. 6, pp. 1101–1108, 2008. View at Publisher · View at Google Scholar · View at Scopus
  22. C. Bombardier, M. Barbieri, A. Parthan et al., “The relationship between joint damage and functional disability in rheumatoid arthritis: a systematic review,” Annals of the Rheumatic Diseases, vol. 71, no. 6, pp. 836–844, 2012. View at Publisher · View at Google Scholar · View at Scopus
  23. J. S. Smolen, J. C. M. Avila, and D. Aletaha, “Tocilizumab inhibits progression of joint damage in rheumatoid arthritis irrespective of its anti-inflammatory effects: disassociation of the link between inflammation and destruction,” Annals of the Rheumatic Diseases, vol. 71, no. 5, pp. 687–693, 2012. View at Publisher · View at Google Scholar · View at Scopus
  24. L. Wu, S. Gonzalez, S. Shah et al., “Extracellular matrix domain formation as an indicator of chondrocyte dedifferentiation and hypertrophy,” Tissue Engineering Part C: Methods, vol. 20, no. 2, pp. 160–168, 2014. View at Publisher · View at Google Scholar
  25. T. Hoshiba, T. Yamada, H. Lu, N. Kawazoe, and G. Chen, “Maintenance of cartilaginous gene expression on extracellular matrix derived from serially passaged chondrocytes during in vitro chondrocyte expansion,” Journal of Biomedical Materials Research—Part A, vol. 100, no. 3, pp. 694–702, 2012. View at Publisher · View at Google Scholar · View at Scopus
  26. V. R. de Sousa, F. das Chagas Araújo Sousa, O. F. da Silva Filho et al., “Comparative study by computed radiography, histology, and scanning electron microscopy of the articular cartilage of normal goats and in chronic infection with caprine arthritis-encephalitis virus,” Microscopy Research and Technique, vol. 77, no. 1, pp. 11–16, 2014. View at Publisher · View at Google Scholar · View at Scopus
  27. G. Schulze-Tanzil, A. Mobasheri, P. de Souza, T. Johns, and M. Shakibaei, “Loss of chondrogenic potential in dedifferentiated chondrocytes correlates with deficient Shc-Erk interaction and apoptosis,” Osteoarthritis and Cartilage, vol. 12, no. 6, pp. 448–458, 2004. View at Publisher · View at Google Scholar · View at Scopus
  28. M. Bayat, E. Ansari, N. Gholami, and A. Bayat, “Effect of low-level helium-neon laser therapy on histological and ultrastructural features of immobilized rabbit articular cartilage,” Journal of Photochemistry and Photobiology B: Biology, vol. 87, no. 2, pp. 81–87, 2007. View at Publisher · View at Google Scholar · View at Scopus
  29. M. Zhang, J. Zhang, L. Lu et al., “Enhancement of chondrocyte autophagy is an early response in the degenerative cartilage of the temporomandibular joint to biomechanical dental stimulation,” Apoptosis, vol. 18, no. 4, pp. 423–434, 2013. View at Publisher · View at Google Scholar · View at Scopus
  30. M.-H. Liu, J.-S. Sun, S.-W. Tsai, S.-Y. Sheu, and M.-H. Chen, “Icariin protects murine chondrocytes from lipopolysaccharide-induced inflammatory responses and extracellular matrix degradation,” Nutrition Research, vol. 30, no. 1, pp. 57–65, 2010. View at Publisher · View at Google Scholar · View at Scopus
  31. D. Li, T. Yuan, X. Zhang et al., “Icariin: a potential promoting compound for cartilage tissue engineering,” Osteoarthritis and Cartilage, vol. 20, no. 12, pp. 1647–1656, 2012. View at Publisher · View at Google Scholar · View at Scopus
  32. F. P. J. G. Lafeber and W. H. Van der Laan, “Progression of joint damage despite control of inflammation in rheumatoid arthritis: a role for cartilage damage driven synovial fibroblast activity,” Annals of the Rheumatic Diseases, vol. 71, no. 6, pp. 793–795, 2012. View at Publisher · View at Google Scholar · View at Scopus
  33. G. Schett and E. Gravallese, “Bone erosion in rheumatoid arthritis: mechanisms, diagnosis and treatment,” Nature Reviews Rheumatology, vol. 8, no. 11, pp. 656–664, 2012. View at Publisher · View at Google Scholar · View at Scopus
  34. X.-F. Li, H. Xu, Y.-J. Zhao et al., “Icariin augments bone formation and reverses the phenotypes of osteoprotegerin-deficient mice through the activation of WNT/β-catenin-BMP signaling,” Evidence-Based Complementary and Alternative Medicine, vol. 2013, Article ID 652317, 13 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  35. N. A. Sims and T.  J. Martin, “Coupling the activities of bone formation and resorption: a multitude of signals within the basic multicellular unit,” BoneKEy Reports, vol. 3, article 481, 2014. View at Publisher · View at Google Scholar
  36. M. J. Martínez-Calatrava, I. Prieto-Potín, J. Roman-Blas et al., “RANKL produced by articular chondrocytes contributes to juxta-articular bone loss in chronic arthritis,” Annals of the Rheumatic Diseases, vol. 71, no. 1, pp. 68–69, 2012. View at Publisher · View at Google Scholar
  37. S. García-López, R. Villanueva, and M. C. Meikle, “Alterations in the synthesis of IL-1β, TNF-α, IL-6, and their downstream targets RANKL and OPG by mouse calvarial osteoblasts in vitro: inhibition of bone resorption by cyclic mechanical strain,” Frontiers in Endocrinology, vol. 4, article 160, 2013. View at Publisher · View at Google Scholar
  38. A. R. Pettit, N. C. Walsh, C. Manning, S. R. Goldring, and E. M. Gravallese, “RANKL protein is expressed at the pannus-bone interface at sites of articular bone erosion in rheumatoid arthritis,” Rheumatology, vol. 45, no. 9, pp. 1068–1076, 2006. View at Publisher · View at Google Scholar · View at Scopus
  39. L. Xiong, J.-U. Jung, H. Wu et al., “Lrp4 in osteoblasts suppresses bone formation and promotes osteoclastogenesis and bone resorption,” Proceedings of the National Academy of Sciences of the United States of America, vol. 112, no. 11, pp. 3487–3492, 2015. View at Publisher · View at Google Scholar · View at Scopus
  40. K. Maruyama, T. Kawagoe, T. Kondo, S. Akira, and O. Takeuchi, “TRAF family member-associated NF-κB activator (TANK) is a negative regulator of osteoclastogenesis and bone formation,” The Journal of Biological Chemistry, vol. 287, no. 34, pp. 29114–29124, 2012. View at Publisher · View at Google Scholar · View at Scopus
  41. F. Long, “Building strong bones: molecular regulation of the osteoblast lineage,” Nature Reviews Molecular Cell Biology, vol. 13, no. 1, pp. 27–38, 2012. View at Publisher · View at Google Scholar · View at Scopus